Recent Advances in Nanoparticle-Mediated Diagnosis and the Treatment of Pancreatic Cancer
Pancreatic cancer (PC), one of the most lethal solid tumors in humans, has a five-year survival rate of only 4%. Surgical treatment is the only accepted therapy with curative intent because the vast majority of these tumors are chemoresistant. Unfortunately, due to the aggressive nature of these tum...
Main Authors: | Andreea Nedelcu, Teodora Mocan, Cristiana Grapa, Lucian Mocan |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/15/8060 |
Similar Items
-
Recent Advances in Nanoparticle-Mediated Treatment of Inflammatory Bowel Diseases
by: Andreea Nedelcu, et al.
Published: (2021-01-01) -
Biomarkers in Pancreatic Cancer as Analytic Targets for Nanomediated Imaging and Therapy
by: Cristiana Maria Grapa, et al.
Published: (2021-06-01) -
Epidermal Growth Factor Receptor and Its Role in Pancreatic Cancer Treatment Mediated by Nanoparticles
by: Grapa CM, et al.
Published: (2019-12-01) -
Nanotechnologies in Pancreatic Cancer Therapy
by: Ayesha Manzur, et al.
Published: (2017-09-01) -
Targeting Pancreatic Cancer Cells and Stellate Cells Using Designer Nanotherapeutics in vitro
by: Elechalawar CK, et al.
Published: (2020-02-01)